Stock BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioForce Nanosciences Holdings, Inc.

Equities

BFNH

US09064C2061

Other Specialty Retailers

Market Closed - OTC Markets
Other stock markets
 12:03:58 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.63 USD +12.41% Intraday chart for BioForce Nanosciences Holdings, Inc. +12.41% -18.91%
Apr. 01 BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 83.18 12.22 11.12 35.13 58.25 58.84
Enterprise Value (EV) 1 83.15 12.16 11.15 35.23 58.42 59.06
P/E ratio -1,228 x -262 x -0.04 x -70 x -120 x -101 x
Yield - - - - - -
Capitalization / Revenue 5,100 x 687 x - - - -
EV / Revenue 5,098 x 684 x - - - -
EV / EBITDA - - - - - -
EV / FCF -1,723 x -527 x 0.19 x 319 x 514 x 453 x
FCF Yield -0.06% -0.19% 532% 0.31% 0.19% 0.22%
Price to Book 2,792 x 258 x -30.9 x -40.8 x -43.2 x -32.3 x
Nbr of stocks (in thousands) 15,262 15,271 29,272 29,272 29,272 29,272
Reference price 2 5.450 0.8000 0.3800 1.200 1.990 2.010
Announcement Date 3/29/19 3/4/20 2/16/21 2/11/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0163 0.0178 - - - -
EBITDA - - - - - -
EBIT 1 -0.0667 -0.0465 -158.4 -0.502 -0.4855 -0.472
Operating Margin -409.2% -261.82% - - - -
Earnings before Tax (EBT) 1 -0.0677 -0.0465 -158.4 -0.502 -0.4855 -0.472
Net income 1 -0.0677 -0.0465 -158.4 -0.502 -0.4855 -0.472
Net margin -415.32% -261.82% - - - -
EPS 2 -0.004438 -0.003048 -9.716 -0.0171 -0.0166 -0.0200
Free Cash Flow 1 -0.0482 -0.0231 59.32 0.1105 0.1137 0.1303
FCF margin -295.82% -129.88% - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 3/4/20 2/16/21 2/11/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 0.03 0.11 0.17 0.22
Net Cash position 1 0.03 0.05 - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.05 -0.02 59.3 0.11 0.11 0.13
ROE (net income / shareholders' equity) -356% -121% 101,349% 82.2% 44% 29.8%
ROA (Net income/ Total Assets) -149% -61.9% -200,497% -1,230% -5,109% -42,999%
Assets 1 0.0455 0.0752 0.079 0.0408 0.009502 0.001098
Book Value Per Share 2 0 0 -0.0100 -0.0300 -0.0500 -0.0600
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/29/19 3/4/20 2/16/21 2/11/22 3/28/23 4/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Health Food Stores

1st Jan change Capi.
BIOFORCE NANOSCIENCES HOLDINGS, INC. Stock BioForce Nanosciences Holdings, Inc.
-18.91% 47.71M
THE BETTER BEING CO. Stock The Better Being Co.
-.--% 843M
DXN HOLDINGS BHD. Stock DXN Holdings Bhd.
-1.57% 657M
NATURAL GROCERS BY VITAMIN COTTAGE, INC. Stock Natural Grocers by Vitamin Cottage, Inc.
+3.94% 384M
ZINZINO AB Stock Zinzino AB
+21.98% 229M
MARX BIOTECH CO., LTD. Stock MARX Biotech Co., Ltd.
0.00% 141M
NANJING SINOLIFE UNITED COMPANY LIMITED Stock Nanjing Sinolife United Company Limited
+115.22% 65.28M
Health Food Stores
  1. Stock Market
  2. Equities
  3. BFNH Stock
  4. Financials BioForce Nanosciences Holdings, Inc.